Bicara Therapeutics: Pricing Details of $315M IPO (Pending: BCAX)
Friday, 13 September 2024, 05:07
Bicara Therapeutics IPO Pricing Announcement
Bicara Therapeutics has successfully priced its Initial Public Offering (IPO) at $18 per share. This offering, which is set to close on September 16, 2024, is anticipated to yield approximately $315 million in gross proceeds. The funds raised will be vital for the company's continuing efforts in medical innovations and potential research breakthroughs.
Key Details
- Offering Size: $315M
- Share Price: $18 per share
- Expected Closing Date: September 16, 2024
For those interested, further updates can be gleaned from additional resources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.